Replies to post #8035 on RespireRx Pharmaceuticals Inc (fka RSPI)

[iggs]

My understanding is that the FDA was going to continue to cull through the 6ft box of docs that the company sent over. The IND still needs to be filed as discussed in the 10-Q. (All that I am saying is something could still go wrong and if it does, what do you think the likelyhood of a PIPE getting done in this market before the company runs out of cash or has to issue a going concern opinion. I hope a BP gets done w/ CX717 and I do think it will but don't you think we would be leaving a lot to chance? I, for one, do not want this company to have to issue stock in the $1.00 range again.

[meixatech]

I sure agree with you about the BPs. A number of BPs have patents running out for major drugs. These BPs must be hungry and more likely than not, are currently engaged in a bidding war for CX-717 and perhaps even the pipeline, including the high impact ampakines. I think Cortex is in a great position and additional investment is a no-brainer.

[JimHaynes]

At last, somebody who understands. Financial strength of the seller is relatively unimportant where there are multiple bidders on the buy side.

JIM